DYN FY 2008 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DYNDyne Therapeutics, Inc.

$3B

FY 2008 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3.5B+14.4% YoY

Gross Profit

$1.7B47.8% margin

Operating Income

$709M20.0% margin

Net Income

$174M4.9% margin

EPS (Diluted)

$0.20

Cash Flow

Operating Cash Flow

$319M

Free Cash Flow

$319M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$14.2B

Total Liabilities

$9.7B

Stockholders' Equity

$4.5B

Cash & Equivalents

$693M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.5B	$3.1B	+14.4%
Gross Profit	$1.7B	$1.1B	+55.6%
Operating Income	$709M	$605M	+17.2%
Net Income	$174M	$264M	-34.1%